Found: 2
Select item for more details and to access through your institution.
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characterization of the Kinase Domain of the Ephrin-B3 Receptor Tyrosine Kinase Using a Scintillation Proximity Assay.
- Published in:
- Assay & Drug Development Technologies, 2003, v. 1, n. 4, p. 555
- By:
- Publication type:
- Article